Kopran Ltd (KOPRAN)
·Next Day Close·-1.91%·₹279.4
Key EventTrading window closure announced for insiders
Kopran Ltd (KOPRAN)
·Next Day Close·+0.92%·₹279.3
Key EventCompany clarifies price movement is market-driven with no undisclosed material events.
ImpactShareholders can view the price movement as purely market-driven without hidden risks.Sign up to read impact
Kopran Ltd (KOPRAN)
·Next Day Close·+3.07%·₹268.6
Key EventAllotment of 40,500 ESOP shares approved by CAC
ImpactThe ESOP issuance dilutes existing shareholders' ownership through new share allotment.Sign up to read impact
Kopran Ltd (KOPRAN)
·Next Day Close·+0.53%·₹218.95
Key EventCompany clarifies volume surge is market-driven, not event-related
ImpactShareholders should view the volume increase as normal market activity without hidden implications.Sign up to read impact
Kopran Limited (KOPRAN)
·Next Day Close·-0.85%·₹179.85
Kopran Limited reported Q1 FY2026-27 revenue of [amount not verified], up sharply from [amount not verified] in Q1 FY2025-26, driven by strong API and formulation sales. EBITDA rose to [amount not verified] from ₹0.39 crores YoY, with EBITDA margin expanding to 10.31%. Net profit reached [amount not verified], while finance costs remained stable at [amount not verified]. The company highlighted growth in anti-diabetic and antibiotic APIs, increased export sales, and strategic focus on R&D and regulatory compliance. Forward-looking statements indicate continued investment in capacity and self-reliance. Investors should monitor execution of growth initiatives amid regulatory and market risks.
Sign up to read summaryKopran Limited (KOPRAN)
·Next Day Close·-0.85%·₹179.85
Key EventBoard approved unaudited Q1 FY2026 financial results.
Kopran Limited (KOPRAN)
·Next Day Close·-1.89%·₹200.1
Key EventRecord date set for dividend payment pending AGM approval
ImpactShareholders on the record date will receive the dividend if approved at the upcoming AGM.Sign up to read impact
Kopran Limited (KOPRAN)
·Next Day Close·+4.55%·₹197.6
Kopran Limited received a SEBI-registered share transfer agent certificate confirming compliance with Regulation 74(5) for the quarter ended June 30, 2026, covering dematerialization of securities and cancellation of physical certificates.
Sign up to read summaryKopran Limited (KOPRAN)
·Next Day Close·-1.82%·₹186.2
Kopran Limited announced the appointment of Vijay L Thange as Chief Technical Officer effective June 26, 2026, adding deep pharma operations expertise to its leadership team. The filing confirms the new CTO will oversee technical functions while bringing 36 years of industry experience from CIPLA, RPG Life Sciences, and USV Limited. This strategic addition strengthens the company's technical capabilities ahead of upcoming growth initiatives.
Sign up to read summaryKopran Limited (KOPRAN)
·Next Day Close·-4.24%·₹189.65
Kopran Limited announced that its trading window will close on July 1, 2026, for directors and designated persons until 48 hours after the unaudited Q1 results are declared, with the board meeting date to be communicated later.
Sign up to read summary